Rx (Prescription Medicine)
Nextnib 70 毫克片剂是一种处方药，用于治疗特定类型的肺癌和特发性肺纤维化。应遵医嘱服用，以有效控制病情。
Nextnib 70 毫克片剂是一种靶向治疗药物，用于治疗某些类型的癌症。其活性成分是尼达尼布，一种酪氨酸激酶抑制剂，通过阻断参与癌细胞生长和增殖的特定酶发挥作用。该药物主要用于治疗特发性肺纤维化 (IPF) 以及在既往化疗后进展的某些晚期非小细胞肺癌 (NSCLC)。严格按照医疗保健提供者的处方服用 Nextnib 70 毫克片剂至关重要。请勿压碎、咀嚼或掰开胶囊。常见的副作用可能包括腹泻、恶心、呕吐和肝酶升高。告知医生您已有的任何疾病，特别是肝脏问题，以及您目前正在服用的所有药物。将 Nextnib 70 毫克片剂储存在室温下，避光防潮，并置于儿童接触不到的地方。
其他品牌的 Dasatinib 70 mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
